What is APOC3 – rs5128, rs138326449 and Why Does the Cardio Zoomer Test for It?

Apolipoprotein C-III gene variants

APOC3 variants change the function or expression of apolipoprotein C‑III, a protein that helps control how the body carries and clears triglyceride-rich lipoproteins. Genotyping rs5128 and rs138326449 reveals inherited differences that can explain individual patterns of blood triglycerides and lipid handling when seen alongside other markers.

View Cardio Zoomer

APOC3 – rs5128, rs138326449

Quality and Security

High-quality testing run in a CLIA-certified and CAP-accredited lab in Santa Clara, California.

fortified-health-HIPAA-compliance-pqgjtx4popoe2n0arp68hrz8h2as5rlhgng5b2srk8 1

About APOC3 – rs5128, rs138326449

${ activeTab.tab_content.text }

View ${ activeTab.tab_content.btn_label }

About APOC3 – rs5128, rs138326449

Overview and History

APOC3 is a human gene that encodes apolipoprotein C‑III, a small protein carried on triglyceride-rich lipoproteins. Biochemically, ApoC‑III modulates the breakdown and hepatic uptake of these particles, influencing plasma triglyceride concentrations and lipoprotein composition. The specific variants rs5128 and rs138326449 have different population frequencies and molecular effects. rs5128 is a more common, noncoding variant studied for its effect on APOC3 expression and lipid levels, while rs138326449 is a rarer variant that has been identified in genetic studies as altering APOC3 function. Research into these variants has helped map how inherited differences affect lipid metabolism and downstream biomarker patterns.

Interpreting Highs and Lows

Genetic changes that increase APOC3 expression or ApoC‑III activity are associated with higher circulating triglyceride levels and altered lipoprotein behavior, which show up as specific lipid pattern changes on a panel. Variants that reduce APOC3 function or protein levels tend to associate with lower triglycerides and different lipoprotein profiles. Interpretation requires clinical context: genotype associations are population-level patterns and are best understood together with Cardio Zoomer measurements such as triglycerides, ApoB, lipoprotein(a), inflammatory and metabolic markers.

Featured Test

Cardio Zoomer includes APOC3 variants to add inherited context to biochemical lipid measures. Testing rs5128 and rs138326449 helps explain why a person may show particular triglyceride and lipoprotein patterns, improving the overall picture of lipid handling and supporting more precise interpretation of the panel’s domains.

View Cardio Zoomer

APOC3 – rs5128, rs138326449 FAQs

What is APOC3 – rs5128, rs138326449 and why is it important?

They are genetic variants in the APOC3 gene, which influences apolipoprotein C‑III, a regulator of triglyceride-rich lipoproteins. These variants can change how the body clears triglycerides and how lipoprotein particles behave. Knowing a person’s APOC3 genotype helps explain individual lipid patterns when combined with other test results.

What does it mean if my APOC3 – rs5128, rs138326449 levels are low?

For these genetic markers, “low” usually refers to alleles tied to reduced APOC3 function or lower ApoC‑III activity. That pattern is associated with lower circulating triglyceride levels and different lipoprotein profiles on average. Such findings are one piece of the puzzle and should be interpreted alongside the Cardio Zoomer lipid and metabolic results.

What does it mean if my APOC3 – rs5128, rs138326449 levels are high?

“High” implies presence of alleles linked to increased APOC3 expression or ApoC‑III activity, which are associated with higher triglycerides and altered lipoprotein handling at the population level. Elevated-associated genotypes point to inherited contributions to a lipid pattern, but clinical interpretation requires the full panel and personal medical context.

Why is this biomarker included in the Cardio Zoomer?

APOC3 variants help explain inherited drivers of triglyceride and lipoprotein patterns that biochemical tests alone may not reveal. Including these genotypes adds genetic context to lipid, inflammation, and metabolic domains, improving the ability to characterize individual cardiovascular-related profiles.

Browse Articles

Introducing Cardio Zoomer + Cardio Genetics: Redefining Precision in Cardiovascular Health

Cardiovascular disease remains the leading cause of death worldwide, yet most testing still focuses on surface-level metrics like total cholesterol or...

Christopher McLaughlin

Nov 7, 2025

Cardiovascular Health Research & Innovation

Nutritional Genetics: Optimizing Diet to Reduce Cardiovascular Risk

What do you think of when you hear the term “cardiovascular disease?” Most people immediately think of high cholesterol, but cardiovascular risk goes ...

Leslie Weidner, RDN

Aug 14, 2025

Cardiovascular Health Nutrients

How Toxin Exposure Impacts Your Cardiometabolic Health

A common theme among many of my nutrition clients is that despite eating well, staying active, and managing stress, they feel worn down, inflamed, and...

Leslie Weidner, RDN

Aug 13, 2025

Cardiovascular Health Toxins Longevity

Beyond Cholesterol: Functional Nutrition for Heart Health

When it comes to cardiovascular disease (CVD), many people immediately think of high cholesterol. High cholesterol—a specific type of dyslipidemia or ...

Leslie Weidner, RDN

Jul 2, 2025

Cardiovascular Health Nutrients

About Vibrant:

The Experts Behind  Every Test

Our team is built on collaboration across disciplines to advance the science of wellness and longevity. At Vibrant Wellness, lab scientists, technologists, clinical researchers, doctors, practitioners, longevity advisors, engineers, and regulatory experts work side by side to transform diagnostics.

By uniting diverse expertise under one mission, we pioneer precision testing that empowers providers to uncover root causes, personalize care plans, and optimize patient health outcomes. Every test we develop reflects this commitment—to push boundaries in functional medicine, deliver clear, actionable insights, and support clinicians in helping patients live healthier, longer lives.

View All Tests

Results trusted by over 18,000 functional wellness professionals

We’re the leading provider of specialty wellness lab testing because we develop our testing with rigorous, ongoing research by top clinical experts, doctors, and scientists.

The gold standard of accuracy in  the lab industry

Our tests run on a proprietary 3Dense microchip technology platform that boasts unrivaled specificity and sensitivity. While most other labs carry only CLIA certification, we're CAP-accredited by the College of American Pathologists.

Our Clinical Support Team

We understand that patient care doesn't end with diagnosis. To achieve Vibrant health, patients need clinical support and
obtainable lifestyle changes. Our clinical support team helps providers make informed treatment recommendations, resulting in  better patient outcomes.

Mary Beth Augustine

DCN, RDN, FAND- Lead Clinical Educator

Suzanne Barker

MS, RDN, LD, CTTS, CGP- Clinical Educator

Suzette Garcia

MSc- MHNE- Clinical Educator

Brooke Mader Ganev

MS, CNS, LDN, FDN- Clinical Educator

Adair Anderson

MS, RDN, LDN- Clinical Educator

Lillie Luu Nguyen

DCN, CNS, LDN- Clinical Educator

Jason Barker

ND- Clinical Educator

Emaline Brown

ND- Clinical Educator

Dana Filatova

DCN, CNS, LDN- Clinical Educator

Jessy Dhanjal

ND- Clinical Educator

Nour Amri

MS, LDN, CNS, CKNS- Clinical Educator

Ready to Elevate Your Approach to Precision Wellness?

At Vibrant Wellness, we’re redefining the future of diagnostics—making complex science clear, accessible, and actionable. Whether you're a provider advancing personalized care or a patient seeking data-driven answers, our precision testing gives you the clarity to make informed decisions. Experience the next generation of functional medicine through clinically validated insights and seamless testing solutions.

Become a Provider

Become a Patient